Literature DB >> 16863959

Excimer laser-assisted anterior lamellar keratoplasty for keratoconus, corneal problems after laser in situ keratomileusis, and corneal stromal opacities.

Kamil Bilgihan1, Sengül C Ozdek, Ayça Sari, Berati Hasanreisoğlu.   

Abstract

PURPOSE: To evaluate excimer laser-assisted anterior lamellar keratoplasty to augment thin corneas as in keratoconus (<350 microm) and corneal ectasia after laser in situ keratomileusis (LASIK) and to treat anterior stromal opacities.
SETTING: Ophthalmology Department, School of Medicine, Gazi University, Ankara, Turkey.
METHODS: Thirteen eyes (5 keratoconus, 3 macular dystrophies, 1 post-LASIK ectasia, 1 post-LASIK interstitial keratitis, 3 post-herpetic keratitis sequelae) of 13 patients were included in this prospective study. The treatment group was divided into corneal ectasia and stromal opacity groups. A donor stromal button approximately 350 microm thick received a 100 microm excimer laser ablation on the endothelium. The remaining cornea (epithelium, Bowman's membrane, and stroma) was punched with a 7.5 or 7.7 mm trephine. After transepithelial ablation of the host cornea to 200 mum thickness, the corneal button was sutured with interrupted 10-0 monofilament nylon. Sutures were removed between 3 months and 6 months postoperatively. Preoperative and postoperative simulated keratometric cylinders and corneal thickness values were compared using the Wilcoxon signed rank test. The postoperative spherical equivalent refraction and best spectacle-corrected visual acuity (BSCVA) between the groups were compared using the Mann-Whitney U test.
RESULTS: The mean follow-up was 27.6 months +/- 8.3 (SD). All patients gained 2 lines or more of BSCVA, and no patient lost a line. The mean corneal thickness was 381.2 +/- 88.2 microm preoperatively, which significantly increased to 534.9 +/- 96.6 microm postoperatively (P < .05). The mean preoperative simulated keratometric cylinder was 7.44 +/- 7.18 diopters (D); postoperatively, it decreased to 2.61 +/- 1.73 D (P < .05). There was no significant difference in postoperative spherical equivalent refraction or BSCVA between the groups (P > .05).
CONCLUSIONS: This technique presents a different modality for the treatment of keratoconus, post-LASIK corneal problems, and other corneal stromal opacities with anterior lamellar keratoplasty. Additional studies with more patients and longer follow-up will help determine the role of this technique as a substitute for penetrating keratoplasty in these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16863959     DOI: 10.1016/j.jcrs.2006.02.056

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  Dual laser-assisted lamellar anterior keratoplasty with top hat graft: a laboratory study.

Authors:  Catherine Cleary; Jonathan C Song; Maolong Tang; Yan Li; Ying Liu; Samuel Yiu; David Huang
Journal:  Cornea       Date:  2012-07       Impact factor: 2.651

Review 2.  A review and meta-analysis of corneal cross-linking for post-laser vision correction ectasia.

Authors:  Qi Wan; Dan Wang; HongQuan Ye; Jing Tang; Yu Han
Journal:  J Curr Ophthalmol       Date:  2017-03-15

Review 3.  Lamellar keratoplasty techniques.

Authors:  Nadisha P Singh; Dalia G Said; Harminder Singh Dua
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

Review 4.  Ectasia After Corneal Refractive Surgery: A Systematic Review.

Authors:  Majid Moshirfar; Alyson N Tukan; Nour Bundogji; Harry Y Liu; Shannon E McCabe; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Ophthalmol Ther       Date:  2021-08-20

5.  Visual and Topographic Outcomes of Corneal Collagen Cross Linking for Post LASIK Ectasia.

Authors:  Mohamed H Nasef; Sharif Y El Emam; Tamer I Haleem; Wesam S Shalaby; Waleed A Allam
Journal:  Clin Ophthalmol       Date:  2022-06-20

Review 6.  Current techniques of lamellar keratoplasty for keratoconus.

Authors:  Leopoldo Spadea; Victoria De Rosa
Journal:  Saudi Med J       Date:  2016-02       Impact factor: 1.484

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.